John Moriarty's Insider Trades & SAST Disclosures
John Moriarty's most recent trade in LendingTree Inc. was a trade of 3,678 Common Stock done . Disclosure was reported to the exchange on March 2, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John Moriarty.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 3,678 | 13,238 (0%) | 0% | - | Common Stock | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 3,678 | 7,358 | - | - | Restricted Stock Units | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,993 | 0 | - | - | Restricted Stock Units | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,993 | 10,654 (0%) | 0% | - | Common Stock | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.08 per share. | 02 Mar 2023 | 1,895 | 11,343 (0%) | 0% | 33.1 | 62,687 | Common Stock |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,776 | 1,777 | - | - | Restricted Stock Units | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,776 | 13,119 (0%) | 0% | - | Common Stock | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.08 per share. | 02 Mar 2023 | 1,094 | 9,560 (0%) | 0% | 33.1 | 36,190 | Common Stock |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.00 per share. | 02 Mar 2023 | 910 | 12,209 (0%) | 0% | 33 | 30,030 | Common Stock |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 22,000 | 22,000 | - | - | Restricted Stock Units | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 968 | 9,213 (0%) | 0% | - | Common Stock | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 968 | 0 | - | - | Restricted Stock Units | |
| LendingTree Inc. | John David Moriarty | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.20 per share. | 28 Feb 2023 | 552 | 8,661 (0%) | 0% | 32.2 | 17,774 | Common Stock |
| Olema Pharmaceuticals Inc | John B. Moriarty | EVP, Ch. Legal Officer & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | John B. Moriarty | EVP, CH. LEGAL OFFICER & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 166,250 | 166,250 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | John Moriarty | EVP, Ch. Legal Officer & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2020 | 252,060 | 252,060 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | John Moriarty | EVP, Ch. Legal Officer & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2020 | 161,406 | 161,406 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges